2 documents found, page 1 of 1
Guidelines for the Management of Center-Involving Diabetic Macular Edema: Treat...
Figueira, J; Henriques, J; Carneiro, A; Marques-Neves, C; Flores, R; Castro-Sousa, JP; Meireles, A; Gomes, N; Nascimento, J; Amaro, M; Silva, RDiabetic macular edema (DME) is the main cause of visual impairment associated with diabetic retinopathy (DR) and macular laser, during approximately three decades, and was the single treatment option. More recently, intravitreous injections of anti-angiogenics and corticosteroids modified the treatment paradigm associated with significant vision improvements. Nevertheless, not all patients respond satisfactori...
A Retrospective Analysis of the Real-Life Utilization of Ranibizumab in Patient...
Silva, R; Goncalves, C; Meireles, A; Teixeira, C; Rosa, P; Monteiro-Grillo, M; Canelas, J; Carneiro, A; Flores, RINTRODUCTION: Anti-vascular endothelial growth factor therapy has revolutionized the treatment of wet age-related macular degeneration; however, it is important to monitor actual use of ranibizumab and related treatment outcomes in routine practice. MATERIAL AND METHODS: This was a retrospective, observational study to monitor the 2-year outcomes following ranibizumab treatment for wet age-related macular degen...